Clinical trial
A Phase 2, Partially-Blinded, Randomized, Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole for the Treatment of Trichuris Trichiura Infection in Adults
NCT04713787 is registered in ClinicalTrials.gov with Asociacion Benefica Prisma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Partially-Blinded, Randomized, Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole for the Treatment of Trichuris Trichiura Infection in Adults
- Lead sponsor
- Asociacion Benefica Prisma
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 7, 2024
- Completion date
- May 30, 2027
- Enrollment
- 249 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.